Skip to main content
. 2017 Nov 17;2017(11):CD005067. doi: 10.1002/14651858.CD005067.pub4
Methods Study design: randomised controlled trial
Setting/location: India
Study period: not described
Sample size calculation: not described
Participants Type of Leishmania: L tropica in the area
Inclusion criteria: participants with cutaneous Leishmania confirmed by the presence of L tropica bodies in the slit skin smear stained with Leishman stain.
Exclusion criteria: women of child‐bearing age
N randomised: 20
Withdrawals: 0
N assessed: 20 (100%). Intervention group: 15, control group: 5
Age: range 14‐56 years.
Baseline data: single or multiple lesions, the duration of the lesions varied from 4 to 16 weeks
Interventions Type of interventions:
  • Group 1: itraconazole orally 4 mg/kg per day for 6 weeks (max 200 mg). MNL: 2. MDLBT: 9 weeks

  • Group 2: control group (no treatment)


Duration of follow‐up: 6 weeks, but 3 months for relapses assessment
Outcomes Primary outcome: percentage of participants 'cured' at the end of treatment. The essential criteria for declaring the participant was cured was complete disappearance of the induration or redness in the nodular form and complete healing in the ulcerative form, accompanied by smear positivity conversion
Secondary outcomes: duration of remission and percentage of people with treated lesions that recur within 3 months
Adverse effects
Tertiary outcomes: microbiological or histopathological cure of skin lesions
Time points reported: clinical cure: 4 weeks, clinical and parasitological cure: 6 weeks
Notes Study funding sources: none reported
Possible conflicts of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Proportion of 2 to 4:1
Comment: insufficient detail was reported about the method used to generate the allocation sequence.
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgment
Blinding of participants and personnel (performance bias) All outcomes Unclear risk Insufficient information to permit judgment
Blinding of outcome assessment (detection bias) All outcomes Unclear risk Insufficient information to permit judgment
Incomplete outcome data (attrition bias) All outcomes Unclear risk Insufficient information to permit judgment
Selective reporting (reporting bias) Unclear risk All of the study's pre‐specified (primary and secondary) outcomes that are of interest in the review have been reported
Other bias High risk Sample size calculation and reporting of Leishmania spp involved was not correctly reported